Synergy Health looks to build US empire
Medical sterilising firm Synergy Health has bought US outfit MSI Surgical Solutions for 6.5m pounds.
Medical sterilising firm Synergy Health has bought US outfit MSI Surgical Solutions for 6.5m pounds.
The transaction will be funded out of existing debt facilities.
MSI operates a hospital sterilisation facility in New York, and is the second-largest provider of these outsourced services in the US.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The business recorded revenues of $4.0m (approx. £2.5m) in the year ended December 31st 2011, and has been acquired for a cash consideration that equates to 6.5 times earnings before interest, tax depreciation and amortisation.
Synergy says the big idea is to develop a hospital outsourcing service within the United States, following the acquisition of medical device steriliser BeamOne in April.
Synergy's stock is up 1.7% over the last 12 months.
BS
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
What happens if you can’t pay your tax bill, and what is "Time to Pay"?
Millions are due to file their tax return this Friday as the self-assessment deadline closes. Though the nightmare is not over until you pay the taxman what you owe - or face a penalty. But what happens if you can't afford to pay HMRC your tax bill, and what is "Time to Pay"?
By Kalpana Fitzpatrick Published
-
What does Rachel Reeves’s plan for growth mean for UK investors?
Rachel Reeves says she is going “further and faster” to kickstart the UK economy, but investors are unlikely to be persuaded
By Katie Williams Published